Deprince Race & Zollo Inc Organon & Co. Transaction History
Deprince Race & Zollo Inc
- $4.59 Billion
- Q1 2024
A detailed history of Deprince Race & Zollo Inc transactions in Organon & Co. stock. As of the latest transaction made, Deprince Race & Zollo Inc holds 3,204,796 shares of OGN stock, worth $68.4 Million. This represents 1.31% of its overall portfolio holdings.
Number of Shares
3,204,796
Previous 1,329,987
140.96%
Holding current value
$68.4 Million
Previous $19.2 Million
214.16%
% of portfolio
1.31%
Previous 0.44%
Shares
2 transactions
Others Institutions Holding OGN
# of Institutions
785Shares Held
190MCall Options Held
2.46MPut Options Held
2.27M-
Black Rock Inc. New York, NY33.5MShares$715 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.8MShares$657 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.2MShares$217 Million0.06% of portfolio
-
State Street Corp Boston, MA9.3MShares$198 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il6.18MShares$132 Million0.02% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $5.42B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...